Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril + lercanidipine versus enalapril + hydrochlorothiazide for vascular effects in hypertension with metabolic syndrome
2008-005006-39Phase 4Active
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in hypertension (HTN) and cardiometabolic risk (CMR) comparing Enalapril + lercanidipine with Enalapril + hydrochlorothiazide (2 arms). Primary endpoint: Change in aortic pulse wave velocity. Started Feb 2009; status: active.
02
Drugs
enalaprillercanidipinehydrochlorothiazide
03
Conditions
hypertension (HTN)cardiometabolic risk (CMR)
Beyond the preview
Go deeper on 2008-005006-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005006-39.